Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Long Term Follow-up Study to Evaluate the Safety of Repeated Intra-Articular Injection of SI-613 in Patients with Osteoarthritis.

Next Previous
Trial Profile

Long Term Follow-up Study to Evaluate the Safety of Repeated Intra-Articular Injection of SI-613 in Patients with Osteoarthritis.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Sep 2018

At a glance

  • Drugs Diclofenac-Eatlhyaluronate (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Ono Pharmaceutical; Seikagaku Corporation

    • Most Recent Events

    • 06 Sep 2018 Status changed from recruiting to active, no longer recruiting.
    • 08 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top